Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Mereu

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Blood|November 21, 2018
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignanciesElisa Bergaggio, Chiara Riganti, Giulia Garaffo, et al.
Haematologica|July 11, 2024
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myelomaNoemi Puccio, Gloria Manzotti, Elisabetta Mereu, et al.
Cells|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple MyelomaMaría Labrador, Sara Cozzubbo, Mariangela Porro, et al.
Cancer Research Communications|February 1, 2024
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating TherapyIgnacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, et al.
Haematologica|April 23, 2026
Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myelomaMichela Cumerlato, Monica Maccagno, María Labrador, et al.
Nature Communications|July 27, 2022
Cohesin couples transcriptional bursting probabilities of inducible enhancers and promotersIrene Robles-Rebollo, Sergi Cuartero, Adria Canellas-Socias, et al.
Cell Reports|May 7, 2023
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative marginClaudia Garcia-Diaz, Anni Pöysti, Elisabetta Mereu, et al.
Nature Communications|June 1, 2024
IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic developmentRoshana Thambyrajah, Maria Maqueda, Muhammad Zaki Fadlullah, et al.
Experimental Hematology & Oncology|August 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Experimental Hematology & Oncology|June 13, 2025
Correction: Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Blood|November 21, 2018
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignanciesElisa Bergaggio, Chiara Riganti, Giulia Garaffo, et al.
Haematologica|July 11, 2024
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myelomaNoemi Puccio, Gloria Manzotti, Elisabetta Mereu, et al.
Cells|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple MyelomaMaría Labrador, Sara Cozzubbo, Mariangela Porro, et al.
Cancer Research Communications|February 1, 2024
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating TherapyIgnacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, et al.
Haematologica|April 23, 2026
Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myelomaMichela Cumerlato, Monica Maccagno, María Labrador, et al.
Nature Communications|July 27, 2022
Cohesin couples transcriptional bursting probabilities of inducible enhancers and promotersIrene Robles-Rebollo, Sergi Cuartero, Adria Canellas-Socias, et al.
Cell Reports|May 7, 2023
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative marginClaudia Garcia-Diaz, Anni Pöysti, Elisabetta Mereu, et al.
Nature Communications|June 1, 2024
IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic developmentRoshana Thambyrajah, Maria Maqueda, Muhammad Zaki Fadlullah, et al.
Experimental Hematology & Oncology|August 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Experimental Hematology & Oncology|June 13, 2025
Correction: Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Pageof 5